HCIL on OTC

Hongchang International Co., Ltd

Hongchang International Co., Ltd is an American electromedical and electrotherapeutic apparatus company.1 Its shares trade on OTC under the symbol HCIL.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with ADM TRONICS UNLIMITED, INC., Vivani Medical, Inc. or Neuraxis, INC, or pick any stock.

  • TickerHCIL on OTC1
  • IndustryElectromedical & Electrotherapeutic Apparatus1
  • HeadquartersNV1
  • Incorporated inNV2
  • Business addressRoom 2409, Rongshang Building, Furen Ave, Yangpu Village, Yinxi Subdistrict, Fuqing City, Fuzhou City, 3503002
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Trust. On December 28, 2016, all assets and liabilities of the Company were transferred to the Liquidating Trust (the “Liquidation”).4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

6.3%Gross margin5
-13.4%Operating margin5
-16.5%Net margin5
7.1%Revenue growth, 20245
-1.2%Return on equity5
0.17×Debt to equity5
-$11.4MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue94¢$2.7M
  • Other costs6¢$159.3K
  • Income tax1¢$22.3K

Out of $2.9M in revenue.5 The company lost money this year.

Financial statements

Revenue6785$2.9M in 2024+1652% since 2019
0$1.0M$2.0M$3.0M2019: $163.7K$163.7K20192020: $222.7K$222.7K2020+36%2021: $96.5K$96.5K2021−57%2022: $79.0K$79.0K2022−18%2023: $2.7M$2.7M2023+3289%2024: $2.9M$2.9M2024+7%
Gross profit6785$181.6K in 2024+127% since 2019
0$50.0K$100.0K$150.0K$200.0K2019: $80.1K$80.1K20192020: $104.2K$104.2K2020+30%2021: $66.2K$66.2K2021−36%2022: $51.6K$51.6K2022−22%2023: $69.4K$69.4K2023+34%2024: $181.6K$181.6K2024+162%
Operating income9678105-$383.3K in 2024+55% since 2018
-$600.0K-$400.0K-$200.0K02018: -$247.8K-$247.8K20182019: -$538.1K-$538.1K2019+117%2020: -$278.8K-$278.8K2020−48%2021: -$162.8K-$162.8K2021−42%2022: -$240.0K-$240.0K2022+47%2023: -$469.6K-$469.6K2023+96%2024: -$383.3K-$383.3K2024−18%
Net income9678105-$472.4K in 2024+89% since 2018
-$600.0K-$400.0K-$200.0K02018: -$250.3K-$250.3K20182019: -$488.4K-$488.4K2019+95%2020: -$548.4K-$548.4K2020+12%2021: -$163.0K-$163.0K2021−70%2022: -$240.0K-$240.0K2022+47%2023: -$378.8K-$378.8K2023+58%2024: -$472.4K-$472.4K2024+25%
Fiscal year2018201920202021202220232024
Revenue$163.7K6$222.7K7$96.5K8$79.0K8$2.7M5$2.9M5
Cost of revenue$83.6K6$118.5K7$30.3K8$27.4K8$2.6M5$2.7M5
Gross profit$80.1K6$104.2K7$66.2K8$51.6K8$69.4K5$181.6K5
Research and development
Operating expenses$229.0K8$240.0K10$538.9K5$565.0K5
Operating income-$247.8K9-$538.1K6-$278.8K7-$162.8K8-$240.0K10-$469.6K5-$383.3K5
Interest
Income before tax-$163.0K8-$240.0K10-$444.7K5-$494.7K5
Income tax-$65.9K5-$22.3K5
Net income-$250.3K9-$488.4K6-$548.4K7-$163.0K8-$240.0K10-$378.8K10-$472.4K5
Earnings per share$0.006$0.007$0.008$0.0010$0.005$0.005
Earnings per share (diluted)$0.008$0.0010$0.005$0.005
Shares (weighted, basic)1.0B shares861.7M shares10450.2M shares5518.8M shares5
Shares (weighted, diluted)1.0B shares861.7M shares10450.2M shares5518.8M shares5

Compare Hongchang International Co., Ltd with another company

Corporate structure

Hongchang International Co., Ltd sits at the top of its group. 9 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Hongchang International Co., Ltd

  • Pheng Ang Hooi Filed SC 13D/A on Hongchang International Co., Ltd, latest Oct 4, 2023 (2 filings since Jun 20, 2023)
  • Zengqiang Lin Filed SC 13D on Hongchang International Co., Ltd, latest Sep 7, 2023
  • Zhenzhu Lin Filed SC 13D on Hongchang International Co., Ltd, latest Sep 7, 2023
  • Hongchang International Co., Ltd NV
    • Fujian Hongchang Global Food Co., Ltd. Subsidiary · China
    • Fujian Hongjin Biotechnology Co, Ltd Subsidiary · China
    • Fuqing Hongchang Food Co., Ltd. Subsidiary · China
    • Fuqing Hongchang Global Import Export Co., Ltd. Subsidiary · China
    • Fuqing Hongchang Global Logistics Co., Ltd. Subsidiary · China
    • Hong Chang Biotechnologies (HK) Limited Subsidiary · Hong Kong
    • Hong Chang Global Investment Holdings Limited Subsidiary · British Virgin Islands
    • Hongfu Food (Fujian) Co., Ltd Subsidiary · China

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Hongchang International Co., Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Land$4.4M14 Mar 31, 2025$4.4M14 Dec 31, 2023+0.7%
Construction in progress$16.8M14 Mar 31, 2025$41.4M14 Dec 31, 2023−59.4%
Accumulated depreciation$407.6K14 Mar 31, 2025$18814 Dec 31, 2023+216708.0%
Property and equipment, net$27.1M14 Mar 31, 2025$3.2K14 Dec 31, 2023+849869.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$493.2K14 Mar 31, 2025$895.7K14 Dec 31, 2023−44.9%
Stakes in other companies (equity method)$527.7K14 Mar 31, 2025

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, gross$3.2K14 Mar 31, 2025$3.3K14 Dec 31, 2023−2.5%
Accumulated amortization$37514 Mar 31, 2025$8214 Dec 31, 2023+357.3%

Inventory

ItemLatestA year beforeChange
Inventory, total$36.2K14 Mar 31, 2025$13.7K14 Dec 31, 2023+164.0%

Leadership

Who has led Hongchang International Co., Ltd, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (15)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Fujian Hongchang Global Food Co., Ltd. China3
  • Fujian Hongjin Biotechnology Co, Ltd China3
  • Fuqing Hongchang Food Co., Ltd. China3
  • Fuqing Hongchang Global Import Export Co., Ltd. China3
  • Fuqing Hongchang Global Logistics Co., Ltd. China3
  • Hong Chang Biotechnologies (HK) Limited Hong Kong3
  • Hong Chang Global Investment Holdings Limited British Virgin Islands3
  • Hongfu Food (Fujian) Co., Ltd China3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Heyu Biological Technology CorpJul 6, 2018 to Nov 14, 20232
  • PACIFIC WEBWORKS INCJul 30, 1999 to May 15, 20182

Timeline

  1. May 13, 20258-K Bylaws or fiscal year changed31
  2. Apr 30, 20258-K Change of auditor; Executive or director change32
  3. May 8, 20248-K Executive or director change33
  4. Apr 1, 20248-K Executive or director change34
  5. Nov 28, 20238-K Other events35
  6. Nov 24, 20238-K Bylaws or fiscal year changed36
  7. Nov 21, 20238-K Bylaws or fiscal year changed37
  8. Sep 7, 2023New chief executive Zengqiang Lin becomes CEO16
  9. Sep 7, 20238-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares38
  10. Aug 23, 20238-K Entered a material agreement; Unregistered sale of shares; Change in control39
  11. Aug 14, 20238-K Bylaws or fiscal year changed40
  12. May 25, 2023New chief executive Ban Siong Ang becomes CEO15
  13. Feb 22, 20238-K Executive or director change41
  14. Jan 6, 20228-K Other events42
  15. Mar 12, 2013New chief executive K. Lance Bell becomes CEO17
  16. Feb 3, 2006New chief executive Kenneth W. Bell becomes CEO18

Filings

66 filings to the SEC since October 2021: 7 annual reports, 17 quarterly reports, 14 major events, 9 insider forms, 4 large holders, 15 other. The latest 20:

  1. Aug 13, 2026NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  2. Jun 30, 2026NT 10-K NOTIFICATION OF LATE FILING EDGAR
  3. Jun 29, 20264 EDGAR
  4. Feb 13, 202610-Q QUARTERLY REPORT EDGAR
  5. Jan 22, 2026144 EDGAR
  6. Nov 13, 202510-Q QUARTERLY REPORT EDGAR
  7. Aug 14, 202510-Q QUARTERLY REPORT EDGAR
  8. Aug 11, 202510-KT TRANSITION REPORT EDGAR
  9. May 13, 20258-K CURRENT REPORT EDGAR
  10. Apr 30, 20258-K CURRENT REPORT EDGAR
  11. Mar 28, 202510-K ANNUAL REPORT EDGAR
  12. Nov 13, 202410-Q QUARTERLY REPORT EDGAR
  13. Aug 28, 20248-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
  14. Aug 13, 202410-Q QUARTERLY REPORT EDGAR
  15. May 15, 202410-Q QUARTERLY REPORT EDGAR
  16. May 8, 20248-K CURRENT REPORT EDGAR
  17. Apr 1, 202410-K ANNUAL REPORT EDGAR
  18. Apr 1, 20248-K CURRENT REPORT EDGAR
  19. Apr 1, 20243 EDGAR
  20. Nov 28, 20238-K CURRENT REPORT EDGAR

The 66 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 1 buys and 5 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 25, 2026Lin ZhenzhuDirectorSale9,998$0.11$1.1KForm 4
Jun 24, 2026Lin ZhenzhuDirectorSale5,000$0.11$550Form 4
Jun 23, 2026Lin ZhenzhuDirectorSale1,450$0.12$174Form 4
Sep 28, 2023Ang Ban SiongDirectorSale28,328,194$28,328.19$802.5BForm 4
May 17, 2023TAN HUNG SENGDirectorBuy20,000,000$20,000.00$400.0BForm 4
May 17, 2023Ang Ban SiongDirectorSale68,645,429$68,645.43$4.7TForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Hongchang International Co., Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHongchang International Co., Ltd1
  • CIK0001086303
  • Employer ID (EIN)87-062791046
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company46
  • Incorporated inNevada46
  • Fiscal year endsMarch 311
  • Industry code (SIC)3845 Electromedical & Electrotherapeutic Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressRoom 2409, Rongshang Building, Furen Ave, Yangpu Village, Yinxi Subdistrict, Fuqing City, Fuzhou City, Fujian Province 350300, China1
  • Phone86 180 5901 60501
  • Shares outstanding518,831,367 as of Feb 11, 202613
  • Public float$12.8M as of Sep 30, 202446
  • AuditorEnrome LLP, Singapore PCAOB ID 6907; no auditor attestation of internal control over financial reporting46
  • On EDGAR sinceJul 16, 19991
  • Filings352 in all: 8-K (67), 10-Q (58), 4 (28), 3 (24), CORRESP (21), 10-K (20), 10QSB (18), UPLOAD (17)1
    All 40 form types

    5 (9), 8-K/A (9), 10-Q/A (7), NT 10-K (7), POS AM (7), NT 10-Q (6), 10-12G/A (5), 10KSB (5), 10-K/A (4), 10KSB/A (4), 10QSB/A (4), DEF 14C (4), PRE 14C (4), SC 13D (4), SB-2 (2), SB-2/A (2), 10-12G (1), 10-KT (1), 144 (1), 4/A (1), 424B3 (1), 5/A (1), EFFECT (1), S-1 (1), S-4 (1), S-4/A (1), S-8 (1), S-8 POS (1), SC 13D/A (1), SC 13G (1), SC 13G/A (1), SC 14F1 (1)

  • Latest filingsAnnual report (10-KT) Aug 11, 2025
    Quarterly report (10-Q) Feb 13, 2026
    Latest 8-K (8-K) May 13, 2025

Risk factors and legal proceedings

Legal proceedings

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. There are currently no legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition, or operating results.

The opening of Item 3, Legal Proceedings.46

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
    SEC EDGAROther events
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
    SEC EDGAROther events
  43. 43
  44. 44
  45. 45
  46. 46